DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.

Employees

414

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
14/08/26	€11.10	0.00%	2,386
13/08/26	€11.10	-2.63%	2,869
12/08/26	€11.40	-1.72%	31
11/08/26	€11.60	+1.75%	3
10/08/26	€11.40	0.00%	77

Delayed Quote Xetra

More quotes

Income Statement and Estimates

More financial data

Market Closed - Xetra 16:35:18 14/08/2026 BST			5-day change	1st Jan Change
11.10 ^EUR	0.00%		-2.63%	-9.76%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-08	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	56.32M 65.21M 52.92M 48.13M 90.49M 6.24B 91.98M 620M 242M 3.12B 245M 240M 10.38B	P/E 2024	8.03x	P/E 2025	11.7x
Enterprise Value	38.73M 44.84M 36.39M 33.1M 62.23M 4.29B 63.25M 426M 167M 2.15B 168M 165M 7.14B	EV / Sales 2024	0.41x	EV / Sales 2025	0.81x
Free-Float	28.08%	Yield 2024	8.98%	Yield 2025	8.13%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-08	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
29/09/25	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
15/04/25	DocCheck AG announces Annual dividend, payable on June 02, 2025	CI
09/04/25	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
23/09/24	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
11/04/24	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/09/23	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
13/04/23	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
29/07/22	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
14/04/22	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
28/10/21	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2021	CI
15/04/21	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2020	CI

04-16	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (DocCheck Informationen nach 125 AktG und Tabelle 3 Blocke A bis F Durchfuhrungsverordnung EU 2018 1212 engl)	PU
15/04/25	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (2025 DocCheck Informationen nach 125 AktG englisch und Tabelle 3 Bloecke A to F)	PU
04/05/23	DD: DocCheck AG: Dr. Frank Antwerpes, buy	EQ
05/03/20	DocCheck AG : Notification and public disclosure of transactions by persons	EQ

DocCheck AG Share Price

Stocks

AJ91

DE000A1A6WE6

Healthcare Facilities & Services

Valuation: DocCheck AG

Chart: DocCheck AG

Latest news : DocCheck AG

Press Releases: DocCheck AG

News in other languages: DocCheck AG

Quotes and Performance

Course Extremes

Managers and Directors: DocCheck AG

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

08-05	DocCheck Gruppe: Vorläufige Zahlen zum ersten Halbjahr 2026
05-28	DocCheck : Abstimmungsergebnisse (AJ91 Abstimmungsergebnisse HV2026)
05-28	DocCheck : Nachtrag (AJ91 1 Nachtrag)
05-25	Kalender der Dividendenausschüttungen und Hauptversammlungen vom 25. bis 29. Mai 2026
05-20	Vorläufige Zahlen zum ersten Quartal 2026

1 week	-2.63%
Current month	-4.31%
1 month	-8.26%
3 months	-26.00%
6 months	-17.16%
Current year	-9.76%

1 week	10.7	11.6
1 month	10.7	12
Current year	10.7	15.9
1 year	10.7	15.9
3 years	7	15.9
5 years	7	37.4
10 years	6.7	37.4

Manager	Title	Age	Since
Frank Nicolas Antwerpes CEO	Chief Executive Officer	65	-
Philip Stadtmann DFI	Director of Finance/CFO	-	31/07/2019
Jens Knoop CTO	Chief Tech/Sci/R&D Officer	-	31/07/2019

Director	Title	Age	Since
Joachim Pietzko CHM	Chairman	-	14/12/2014
Winfried Leimeister BRD	Director/Board Member	-	31/12/1998
Karin Immenroth BRD	Director/Board Member	-	30/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOCCHECK AG	0.00%	-2.63%	-5.13%	+12.69%	65.21M
CVS HEALTH CORPORATION	+2.28%	+1.53%	+41.63%	+32.50%	124B
HCA HEALTHCARE, INC.	-1.71%	-2.10%	+2.25%	+50.57%	87.61B
FRESENIUS SE & CO. KGAA	-1.22%	+0.04%	+2.33%	+56.99%	30.7B
QUEST DIAGNOSTICS INCORPORATED	-0.69%	-1.66%	+30.39%	+75.54%	25.87B
TENET HEALTHCARE CORPORATION	+0.32%	+2.20%	+55.74%	+267.39%	21.57B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.96%	-1.62%	-9.21%	-13.31%	21.29B
REDE D'OR SÃO LUIZ S.A.	-2.55%	-0.77%	-10.31%	+9.46%	14.02B
FRESENIUS MEDICAL CARE AG	+0.12%	-2.40%	-3.73%	-9.60%	12.59B
DAVITA INC.	+0.50%	-2.02%	+33.00%	+71.16%	11.48B
Average	-0.20%	-0.54%	+13.70%	+55.34%	34.95B
Weighted average by Cap.	+0.22%	+0.48%	+21.23%	+52.90%

	2024	2025
Net sales	53.79M 62.27M 50.54M 45.97M 86.42M 5.95B 87.84M 592M 232M 2.98B 234M 229M 9.91B	55.32M 64.04M 51.98M 47.27M 88.88M 6.12B 90.34M 609M 238M 3.07B 240M 235M 10.19B
Net income	5.28M 6.12M 4.96M 4.52M 8.49M 585M 8.63M 58.17M 22.74M 293M 22.97M 22.47M 973M	5.33M 6.18M 5.01M 4.56M 8.57M 591M 8.71M 58.73M 22.96M 296M 23.19M 22.68M 983M
Net Debt	-20.11M -23.28M -18.9M -17.18M -32.31M -2.23B -32.84M -221M -86.56M -1.11B -87.41M -85.51M -3.7B	-17.59M -20.37M -16.53M -15.03M -28.26M -1.95B -28.73M -194M -75.72M -975M -76.46M -74.8M -3.24B